WAM
NVAX icon

Weiss Asset Management’s Novavax NVAX Stock Holding History

Weiss Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,027
Closed -$75K – 482
2018
Q4 		$75K Buy
2,027
+874
+76% +$33.9K 0.01% 408
2018
Q3 		$43K Sell
1,153
-2,518
-69% -$70.9K ﹤0.01% 190
2018
Q2 		$98K Buy
3,671
+2,518
+218% +$85.1K 0.01% 168
2018
Q1 		$48K Hold
1,153
– – ﹤0.01% 222
2017
Q4 		$29K Buy
1,153
+557
+93% +$13.6K ﹤0.01% 259
2017
Q3 		$14K Buy
+596
New +$13.3K ﹤0.01% 110

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Weiss Asset Management's NVAX Position: Q1 2019 in Review

Weiss Asset Management sold out of Novavax (NVAX) in Q1 2019, closing a stake of 2,027 shares — an estimated $75K sold.

Weiss Asset Management first reported a position in NVAX in Q3 2017 and held it in 6 quarters. The position peaked at $98K in Q2 2018. 140 funds tracked by Wall St. Rank hold NVAX as of Q1 2019.

  • Weiss Asset Management reported no remaining Novavax position as of Q1 2019 after selling out during the quarter.
  • Weiss Asset Management sold 2,027 Novavax shares in Q1 2019, an estimated $75K.
  • Weiss Asset Management first reported a position in Novavax in Q3 2017 and held it in 6 quarters.
  • Weiss Asset Management's Novavax position peaked at $98K in Q2 2018.
  • 140 funds tracked by Wall St. Rank held Novavax as of Q1 2019.

Based on Weiss Asset Management's 13F filing for Q1 2019, filed 15 May 2019.